Clinical Trial Update: Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of buprenorphine/naloxone for opioid-dependent adolescents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (Suboxone) (buprenorphine/naloxone)

Snippet

Sponsor: University of Pennsylvania | Conditions: Opioid-Related Disorders | Phase 3 | Status: COMPLETED